United States · FDA National Drug Code directory

RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN

Source ingredient · 5 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 63083-4012_268fdf1c-5082-4f20-b0d8-fcf2f0a4cce0

Herpetic Nosode 4012

LIQUID / Professional Complementary Health Formulas

United States · Source reference 63083-9233_6807acea-520d-4492-b4cd-03e2d6ef8863

Mercurius Combination 9233

LIQUID / Professional Complementary Health Formulas

United States · Source reference 63083-4028_a45a894a-e945-4f1f-81d1-9490db8da397

Shingles Nosode 4028

LIQUID / Professional Complementary Health Formulas

United States · Source reference 50090-7919_3cc5ee17-3376-493a-8146-42df66edb945

Shingrix

INJECTION, SOLUTION / A-S Medication Solutions

United States · Source reference 58160-849_844a535e-3d0e-46fe-b672-10605bedbb71

Shingrix

INJECTION, SOLUTION / GlaxoSmithKline Biologicals SA

Browse ingredients in United States →
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN | Molindra Medicines